Cue Biopharma Inc (CUE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,178 | -22,518 | -12,347 | -50,733 | -37,299 |
| Depreciation Amortization | 327 | 216 | 108 | 359 | 237 |
| Accounts receivable | -1,454 | -149 | 298 | -1,641 | -1,603 |
| Other Working Capital | -4,024 | -2,752 | -274 | -934 | -287 |
| Other Operating Activity | 9,028 | 5,429 | 2,431 | 12,988 | 9,949 |
| Operating Cash Flow | $-27,301 | $-19,774 | $-9,784 | $-39,961 | $-29,003 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 25,000 | 25,000 |
| PPE Investments | 33 | -65 | -55 | 2 | 2 |
| Investing Cash Flow | $33 | $-65 | $-55 | $25,002 | $25,002 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 10,821 | N/A | N/A | 473 | 473 |
| Other Financing Activity | 354 | 1,354 | 2,354 | 11,387 | 6,605 |
| Financing Cash Flow | $11,175 | $1,354 | $2,354 | $11,860 | $7,078 |
| Beginning Cash Position | 48,665 | 48,665 | 48,665 | 51,764 | 51,764 |
| End Cash Position | 32,572 | 30,180 | 41,180 | 48,665 | 54,841 |
| Net Cash Flow | $-16,093 | $-18,485 | $-7,485 | $-3,099 | $3,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,301 | -19,774 | -9,784 | -39,961 | -29,003 |
| Capital Expenditure | -64 | -65 | -55 | N/A | N/A |
| Free Cash Flow | -27,365 | -19,839 | -9,839 | -39,961 | -29,003 |